EVEXIA LIFECARE LIMITED Share History & Returns 2021 to 2026
|
EVEXIA LIFECARE LIMITED |
|||
|
Price: ₹1.75 (2.94%) | ||
| 52 Week Low: ₹0.47 52 Week High: ₹2.69 |
|||
| Market Capital: 153.94 Crore (Small-cap) | |||
| -> | |||
Show Table of Contents
Table of Contents
- 1: EVEXIA LIFECARE LIMITED Stock Highlights
- 1.1: 52-Week High Low
- 1.2: All Time High
- 2: EVEXIA LIFECARE LIMITED Recent Performance
- 3: EVEXIA LIFECARE LIMITED Stock Price Chart From 2021 to 2026
- 4: EVEXIA LIFECARE LIMITED Stock Price History Table From 2021 to 2026
- 5: Analyzing the Impact of Investing in EVEXIA LIFECARE LIMITED
- 5.1: EVEXIA LIFECARE LIMITED Stock Returns In Last 5 Years
- 6: EVEXIA LIFECARE LIMITED Returns vs Bank FD Returns
EVEXIA LIFECARE LIMITED Stock Highlights
As of 12 Jun 2026, EVEXIA LIFECARE LIMITED Stock price is ₹1.75 which is ₹0.94 below 52-week high of ₹2.69 and ₹1.28 above 52-week low of ₹0.47
52-Week High Low
- EVEXIA LIFECARE LIMITED 52-Week High is ₹2.69 occurred on 30 Jun 2025
- EVEXIA LIFECARE LIMITED 52-Week Low is ₹0.47 occurred on 06 Apr 2026
All Time High
- The all-time high or the highest price that EVEXIA LIFECARE LIMITED stocks have ever touched was ₹165.00 and this occurred on Mar 2021.
- The highest closing price at which EVEXIA LIFECARE LIMITED stocks have ever closed was ₹146.75 recorded on Mar 2021.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
EVEXIA LIFECARE LIMITED Recent Performance
Over the past 15 trading days, the value of EVEXIA LIFECARE LIMITED's stock has increased by ₹0.19 (+12.18%). On 22 May 2026, its one share was worth ₹1.56 and by 12 Jun 2026, the value jumped to ₹1.75. During this period it created a highest high of ₹1.95 and lowest low of ₹1.53.
Click on legend items to show/hide respective price lines
EVEXIA LIFECARE LIMITED Stock Price Chart From 2021 to 2026
Click on legend items to show/hide respective price lines
EVEXIA LIFECARE LIMITED Stock Price History Table From 2021 to 2026
| Year | EVEXIA LIFECARE LIMITED | YOY Chg% | ↑High - ↓Low |
|---|---|---|---|
| 2026 | ₹1.88 | 14.6% |
↑ ₹1.95 ↓ ₹0.47 |
| 2025 | ₹1.64 | -52.5% |
↑ ₹3.73 ↓ ₹1.52 |
| 2024 | ₹3.45 | 83.5% |
↑ ₹4.40 ↓ ₹1.87 |
| 2023 | ₹1.88 | 19.7% |
↑ ₹3.15 ↓ ₹1.30 |
| 2022 | ₹1.57 | -84.6% |
↑ ₹11.50 ↓ ₹1.40 |
| 2021 | ₹10.13 | - |
↑ ₹165.00 ↓ ₹9.55 |
Analyzing the Impact of Investing in EVEXIA LIFECARE LIMITED
EVEXIA LIFECARE LIMITED Stock price in the year 2021 was ₹10.13. If you had invested ₹10,000 in EVEXIA LIFECARE LIMITED Stock in 2021, in 5 years, your investment would have reduced to ₹1,855 by the end of 2026. This represents a negative return of -81.5% from 2021 to 2026, with a compound annual growth rate (CAGR) of -28.6%.
EVEXIA LIFECARE LIMITED Stock Returns In Last 5 Years
- Its highest stock price in the last 5 years was: ₹165.00 and lowest was: ₹0.47
- EVEXIA LIFECARE LIMITED Stock price in 2021 was ₹10.13
- By 2026, its stock price dropped to ₹1.88
- It gave a negative return of over -81.4% with a CAGR of -28.6% over the last 5 years
- If you had invested ₹10,000 in EVEXIA LIFECARE LIMITED in 2021 then in 5 years, your investment would have declined to ₹1,855.87 by 2026.
EVEXIA LIFECARE LIMITED Returns vs Bank FD Returns
| Investment Type | Initial Amount | Final Value | Total Returns |
|---|---|---|---|
| EVEXIA LIFECARE LIMITED Shares | ₹10,000 | ₹1,855.87 | -81.4% |
| Bank FD (Simple Interest) | ₹10,000 | ₹13,000 | 30.0% |
| Bank FD (Compound Interest) | ₹10,000 | ₹13,382.25 | 33.8% |
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
